Veru Inc.

NASDAQ:VERU

0.77 (USD) • At close September 18, 2024
Bedrijfsnaam Veru Inc.
Symbool VERU
Munteenheid USD
Prijs 0.77
Beurswaarde 112,715,680
Dividendpercentage 0%
52-weken bereik 0.36 - 1.92
Industrie Biotechnology
Sector Healthcare
CEO Dr. Mitchell S. Steiner F.A.C.S, F.A.C.S., M.D.
Website https://www.verupharma.com

An error occurred while fetching data.

Over Veru Inc.

Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial

Vergelijkbare Aandelen

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

52.77 USD

MannKind Corporation logo

MannKind Corporation

MNKD

6.66 USD

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

1.35 USD

NeoGenomics, Inc. logo

NeoGenomics, Inc.

NEO

16.16 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

88.85 USD

Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

SAVA

30.32 USD

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

91.54 USD

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.49 USD

Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc.

ARQT

10.4 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)